Loading organizations...

Active investment manager for institutional clients, focusing on fixed income, equities, credit, and emerging debt strategies.
Blue Bay Fund I operates a customizable debt and equity fund, focused on real estate investments through secured loans and equity positions in joint ventures and syndications across the Southeastern US. Its approach features fractional capital allocation, enabling accredited investors to select and diversify capital across vetted opportunities, moving beyond traditional blind pools.
The fund is managed by Edwin D Epperson III, who initiated private real estate loan investments in 2014. Mr. Epperson’s foundational experience includes a distinguished 13.5-year career in the US Army (2002-2015), encompassing seven combat deployments and rigorous training, notably earning a Green Beret. This background provides a disciplined, strategic framework for management.
Blue Bay Fund I serves accredited investors seeking transparent, tailored real estate investment experiences with enhanced portfolio control. The vision is to redefine alternative investing by offering flexible, manager-aligned opportunities where investors actively curate their allocations, delivering consistent income and robust diversification for sophisticated capital.
Blue Bay Capital has 1 tracked investment across 1 company. The latest tracked deal is $45.0M Series A in Thousand Oaks Biopharmaceuticals in January 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 3, 2019 | Thousand Oaks Biopharmaceuticals | $45.0M Series A | Liefeng Qu | Ji Lin Ao Dong, Qianrong Holdings, Tenyall & Sumin |